Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2010-04-14 | Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton brings to the board extensive executive, international operations management, and technical expertise in the life sciences industry. |
| 2011-04-11 | Dr. Linton received a B.S. degree from University of California, Berkeley and an honorary Ph.D. from Hannam University. |
| 2012-04-13 | Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton brings to the board extensive executive, international operations management, and technical expertise in the life sciences industry. |
| 2013-04-10 | Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has extensive executive, international operations management and technical expertise in the life sciences industry. |
| 2014-04-16 | Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has extensive executive, international operations management and technical expertise in the life sciences industry. |
| 2015-04-14 | Dr. Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry. |
| 2016-04-22 | Dr. Linton received a B.S. degree from University of California, Berkeley in 1970 and an honorary Ph.D. from Hannam University (Korea) in 2004. Dr. Linton has been a director of the Wisconsin Technology Council since 2001 and also serves as a director of ALDA (Analytical, Life Science & Diagnostics Association), an industry association formerly known as Analytical & Life Sciences Systems Association, or ALSSA, and Heffter Research Institute, a non-profit medical research organization, and is President of the BioPharmaceutical Technology Center Institute. Dr. Linton brings to the board extensive executive, international operations management and technical expertise in the life sciences industry, as well as significant experience in strategic planning, corporate governance, and public company executive compensation matters. |
Data sourced from SEC filings. Last updated: 2026-02-03